Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagy

Leilei Xia; Ye Wang; Ya Chen; Jiuqiong Yan; Fan Hao; Xiaoling Su; Caihong Zhang; Mingjuan Xu

doi:10.18632/oncotarget.17854

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagy

Leilei Xia, Ye Wang, Ya Chen, Jiuqiong Yan, Fan Hao, Xiaoling Su, Caihong Zhang and Mingjuan Xu _

PDF | HTML | How to cite

Oncotarget. 2017; 8:61083-61092. https://doi.org/10.18632/oncotarget.17854

Metrics: PDF 1302 views | HTML 2818 views | ?

Abstract

Leilei Xia1,*, Ye Wang2,*, Ya Chen3, Jiuqiong Yan1, Fan Hao1, Xiaoling Su1, Caihong Zhang1 and Mingjuan Xu1

1Department of Obstetrics and Gynaecology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China

2Department of Urology, Changhai Hospital, The Second Military Medical University, Shanghai 200433, P.R. China

3Department of Obstetrics and Gynecology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Mingjuan Xu, email: [email protected]

Keywords: cuprous oxide nanoparticle, cervical cancer, nanomedicine, therapy, AKT/mTOR pathway

Abbreviations: DDP: Cisplatin.

Received: February 13, 2017 Accepted: April 12, 2017 Published: May 15, 2017

ABSTRACT

Cervical carcinoma is one of the main causes of women’s cancer, and substantial side effects from standard treatment including platinum-based chemotherapy limit the options for escalation. In this paper, using cervical cancer cell lines and tumor-bearing mice as models, we report that CONPs could inhibit the proliferation of cancer cells in vitro and in vivo. Especially CONPs could inhibit tumor growth as cisplatin without weight loss. CONPs could also induce autophagy through AKT/mTOR pathway, which demonstrates that CONPs has the potential clinical applications.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17854

Publication Alerts

Research Papers:

Cuprous oxide nanoparticles inhibit the growth of cervical carcinoma by inducing autophagy

Abstract